Christopher Silber

Christopher Silber

Nessuna posizione attualmente
Health Technology
Consumer Services

Profilo

Christopher Silber worked as a Principal at Hospira, Inc. He then served as the Vice President-Clinical Affairs at OVATION Pharmaceuticals, Inc. from 2008 to 2010.
Later, he held the position of Senior Vice President-Clinical Development at SAGE Therapeutics, Inc. from 2017 to 2020.
Dr. Silber also worked as the Chief Medical Officer at Nocion Therapeutics, Inc. Currently, he is the Chief Medical Officer at Vigil Neuroscience, Inc. Dr. Silber completed his undergraduate studies at Tufts University and obtained a doctorate degree from Jacobs School of Medicine & Biomedical Sciences.

Precedenti posizioni note di Christopher Silber

SocietàPosizioneFine
VIGIL NEUROSCIENCE, INC. Direttore Tecnico/Scientifico/R&S 20/03/2024
SAGE THERAPEUTICS, INC. Direttore Tecnico/Scientifico/R&S -
Direttore Tecnico/Scientifico/R&S 29/03/2010
Direttore Tecnico/Scientifico/R&S -
HOSPIRA, INC. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Christopher Silber

Formazione di Christopher Silber

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

28

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Christopher Silber